Latest papers

Granulocytapheresis in the treatment of severe alcoholic hepatitis: a case series.

[Emergency checklist: acute hearing loss]

[Quality and safety about hemapheresis practicing: from a self-evaluation of medical practices to a systematic risk management process].

Sporadic formation of cryoprecipitate-like particulate matter in thawed fresh-frozen plasma units.

Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.

Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.

Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.

Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.

Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.

Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.

Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards.

Facilitating blood component preparation: the impact of overnight room temperature storage.

Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.

Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.

Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.

Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.

Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.

Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.

Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.

Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.